Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium fluoride + tricalcium phosphate is a combination used primarily in prescription-strength toothpastes and varnishes for the prevention and control of dental caries (tooth decay) and to promote remineralization of enamel. Sodium fluoride acts by enhancing the uptake of fluoride ions into tooth enamel, making it more resistant to acid demineralization. Functionalized tricalcium phosphate (fTCP) is designed to deliver bioavailable calcium and phosphate ions while preventing premature interaction with fluoride; this enhances the nucleation activity for remineralization at the tooth surface[2][6][8]. The combination is indicated especially for patients at high risk for caries or orthodontic decalcification[1][6]. It is typically self-applied as a dentifrice or varnish under professional supervision.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sodium fluoride + tricalcium phosphate.